MUC16 and neoplasm: Their analysis predicted that the inclusion of microbial profiles with serum tumor markers (CA125 and HE4) and controlled features (patient age and BMI) would increase the diagnostic accuracy (AUC 0.904) compared to current screening methods with just serum CA125 and HE4 (AUC 0.804) [278].